2.190USD+2.82%Mkt Cap: 23.51M USDP/E: —Last update: 2026-05-22
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hype…
Industry Peers
Drug Manufacturers - Specialty & Generic153.28BSEKP/E 169.8
56.23BTRYP/E 26.9
55.91BEURP/E 22.1
33.39BPLNP/E 21.7
13.24BSEKP/E 39.8
13.20BEURP/E 30.1
12.83BTRY—
10.85BUSD—
loading…
Indicators:|
Key Statistics
Company
Market Cap23.51M USD
Enterprise Value17.96M USD
Revenue (TTM)56.60M USD
Gross Profit45.83M USD
Net Income (TTM)-13.56M USD
Revenue/Share6.158 USD
Last Price2.190 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees82
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS0547548588
Valuation
P/E (Trailing)—
P/E (Forward)-42.60
PEG—
EV/EBITDA-6.84
EV/Revenue0.32
P/S0.40
P/B0.65
EPS (TTM)-4.61
EPS (Forward)-0.05
52W Range
1.46045% of range3.070
52W High3.070 USD
52W Low1.460 USD
Profitability
Gross Margin69.04%
Oper. Margin-32.74%
EBITDA Margin-4.64%
Profit Margin-20.43%
ROE-71.51%
ROA-10.92%
Growth
Revenue Growth-32.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.94M USD
CapEx (TTM)3.23M USD
FCF Margin-1.90%
FCF Yield-4.57%
Net Debt-4.90M USD
Net Debt/EBITDA1.87
Balance Sheet
Debt/Equity1.15
Current Ratio1.12
Quick Ratio0.85
Book Value/Sh3.274 USD
Cash/Share2.489 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 9, 2020
Splits
Last Split1:20
Split DateJan 6, 2023
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)9.333 USD
Target Range7.000 USD – 14.00 USD
# Analysts3
Ownership
Shares Out.10.73M
Float7.61M
Insiders8.98%
Institutions36.58%
Short Interest
Short Ratio14.8d
Short % Float5.48%
Short % Out.4.71%
Shares Short505.37K
Short (prev mo.)503.36K
Technical
SMA 502.524 (-13.2%)
SMA 2002.383 (-8.1%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)46.36K
Avg Vol (10d)75.66K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—